BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 18672194)

  • 21. Extracellular matrix alterations in patients with paroxysmal and persistent atrial fibrillation: biochemical assessment of collagen type-I turnover.
    Kallergis EM; Manios EG; Kanoupakis EM; Mavrakis HE; Arfanakis DA; Maliaraki NE; Lathourakis CE; Chlouverakis GI; Vardas PE
    J Am Coll Cardiol; 2008 Jul; 52(3):211-5. PubMed ID: 18617070
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Interleukin-4 and cardiac fibrosis in patients with heart failure].
    Roselló-Lletí E; Rivera M; Bertomeu V; Cortés R; Jordán A; González-Molina A
    Rev Esp Cardiol; 2007 Jul; 60(7):777-80. PubMed ID: 17663863
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Peripheral blood levels of matrix metalloproteinases in patients referred for percutaneous balloon mitral valve commissurotomy.
    Garr RJ; Krasuski RA; Eckart RE; Wang A; Pierce C; Kisslo KB; Harrison JK; Bashore TM
    J Heart Valve Dis; 2006 May; 15(3):369-74. PubMed ID: 16784074
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Early changes in serum markers of cardiac extra-cellular matrix turnover in patients with uncomplicated hypertension and type II diabetes.
    Alla F; Kearney-Schwartz A; Radauceanu A; Das Dores S; Dousset B; Zannad F
    Eur J Heart Fail; 2006 Mar; 8(2):147-53. PubMed ID: 16198628
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The outer wall of small airways is a major site of remodeling in fatal asthma.
    Dolhnikoff M; da Silva LF; de Araujo BB; Gomes HA; Fernezlian S; Mulder A; Lindeman JH; Mauad T
    J Allergy Clin Immunol; 2009 May; 123(5):1090-7, 1097.e1. PubMed ID: 19361849
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Usefulness of Type D personality and kidney dysfunction as predictors of interpatient variability in inflammatory activation in chronic heart failure.
    Denollet J; Schiffer AA; Kwaijtaal M; Hooijkaas H; Hendriks EH; Widdershoven JW; Kupper N
    Am J Cardiol; 2009 Feb; 103(3):399-404. PubMed ID: 19166697
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Proteinuria, chronic kidney disease, and the effect of an angiotensin receptor blocker in addition to an angiotensin-converting enzyme inhibitor in patients with moderate to severe heart failure.
    Anand IS; Bishu K; Rector TS; Ishani A; Kuskowski MA; Cohn JN
    Circulation; 2009 Oct; 120(16):1577-84. PubMed ID: 19805651
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro study of matrix metalloproteinase/tissue inhibitor of metalloproteinase production by mesenchymal stromal cells in response to inflammatory cytokines: the role of their migration in injured tissues.
    Tondreau T; Meuleman N; Stamatopoulos B; De Bruyn C; Delforge A; Dejeneffe M; Martiat P; Bron D; Lagneaux L
    Cytotherapy; 2009; 11(5):559-69. PubMed ID: 19551542
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Is interleukin-22 a possible indicator of chronic heart failure's progression?
    Gangemi S; Parisi P; Ricciardi L; Saitta S; Minciullo PL; Cristani MT; Nicita-Mauro V; Saija A; Basile G
    Arch Gerontol Geriatr; 2010; 50(3):311-4. PubMed ID: 19523698
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Limitation of excessive extracellular matrix turnover may contribute to survival benefit of spironolactone therapy in patients with congestive heart failure: insights from the randomized aldactone evaluation study (RALES). Rales Investigators.
    Zannad F; Alla F; Dousset B; Perez A; Pitt B
    Circulation; 2000 Nov; 102(22):2700-6. PubMed ID: 11094035
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Admission or changes in renal function during hospitalization for worsening heart failure predict postdischarge survival: results from the Outcomes of a Prospective Trial of Intravenous Milrinone for Exacerbations of Chronic Heart Failure (OPTIME-CHF).
    Klein L; Massie BM; Leimberger JD; O'Connor CM; Piña IL; Adams KF; Califf RM; Gheorghiade M;
    Circ Heart Fail; 2008 May; 1(1):25-33. PubMed ID: 19808267
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum procollagen type III is associated with elevated right-sided filling pressures in stable outpatients with congestive heart failure.
    Biolo A; Rohde LE; Goldraich LA; Mascarenhas M; Palombini DV; Clausell N
    Biomarkers; 2009 Sep; 14(6):438-42. PubMed ID: 19594402
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Extracellular matrix remodeling attenuated after experimental postinfarct left ventricular aneurysm repair.
    Hsu CP; Huang CY; Wang JS; Sun PC; Shih CC
    Ann Thorac Surg; 2008 Oct; 86(4):1243-9. PubMed ID: 18805169
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Associations of inflammatory and haemostatic biomarkers with poor outcome in acute ischaemic stroke.
    Welsh P; Barber M; Langhorne P; Rumley A; Lowe GD; Stott DJ
    Cerebrovasc Dis; 2009; 27(3):247-53. PubMed ID: 19176958
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An inverse relationship between markers of fibrogenesis and collagen degradation in patients with or without alcoholic liver disease.
    Koivisto H; Hietala J; Niemelä O
    Am J Gastroenterol; 2007 Apr; 102(4):773-9. PubMed ID: 17222322
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serum cortisol as a useful predictor of cardiac events in patients with chronic heart failure: the impact of oxidative stress.
    Yamaji M; Tsutamoto T; Kawahara C; Nishiyama K; Yamamoto T; Fujii M; Horie M
    Circ Heart Fail; 2009 Nov; 2(6):608-15. PubMed ID: 19919986
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Transforming growth factor beta, metalloproteinase 2 and its tissue inhibitor 2 in the serum from patients with early and late boreliosis].
    Pancewicz SA; Izycka A; Klibingat M; Zajkowska JM; Swierzbińska-Pijanowska R; Kondrusik M; Grygorczuk SS; Izycki T; Hermanowska-Szpakowicz T
    Pol Merkur Lekarski; 2008 Dec; 25(150):495-9. PubMed ID: 19205380
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genetic polymorphisms of the matrix metalloproteinase-3 (MMP-3) and tissue inhibitors of matrix metalloproteinases-1 (TIMP-1) modulate the development of ankylosing spondylitis.
    Wei JC; Lee HS; Chen WC; Shiu LJ; Yang SF; Wong RH
    Ann Rheum Dis; 2009 Nov; 68(11):1781-6. PubMed ID: 19019896
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Potential relevance of cerebrospinal fluid and serum levels and intrathecal synthesis of active matrix metalloproteinase-2 (MMP-2) as markers of disease remission in patients with multiple sclerosis.
    Fainardi E; Castellazzi M; Tamborino C; Trentini A; Manfrinato MC; Baldi E; Tola MR; Dallocchio F; Granieri E; Bellini T
    Mult Scler; 2009 May; 15(5):547-54. PubMed ID: 19318509
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunological investigation in the adenoid tissues from children with chronic rhinosinusitis.
    Shin SY; Choi GS; Park HS; Lee KH; Kim SW; Cho JS
    Otolaryngol Head Neck Surg; 2009 Jul; 141(1):91-6. PubMed ID: 19559965
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.